Effect of Ketoconazole on the Pharmacokinetic Profile of Buprenorphine following Administration of a Once-Weekly Buprenorphine Transdermal System

作者: Ram P. Kapil , Alessandra Cipriano , Gregory H. Michels , Peter Perrino , Sarah A. O’Keefe

DOI: 10.1007/BF03261913

关键词:

摘要: Background and Objective: Buprenorphine is extensively metabolized by cytochrome P450 (CYP) 3A4. This study evaluated the effect of ketoconazole, a CYP3A4 inhibitor, on metabolism buprenorphine following administration transdermal system 10μg/hour (BTDS 10).

参考文章(27)
Grant R. Wilkinson, David G. Shand, A physiological approach to hepatic drug clearance Clinical Pharmacology & Therapeutics. ,vol. 18, pp. 377- 390 ,(1975) , 10.1002/CPT1975184377
A Cowan, JW Lewis, Buprenorphine: combatting drug abuse with a unique opioid Wiley-Liss Inc.. ,(1995)
Toshiro Niwa, Toshifumi Shiraga, Akira Takagi, Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes. Biological & Pharmaceutical Bulletin. ,vol. 28, pp. 1805- 1808 ,(2005) , 10.1248/BPB.28.1805
J. Lundahl, C. G. Regårdh, B. Edgar, G. Johnsson, Effects of grapefruit juice ingestion - pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men European Journal of Clinical Pharmacology. ,vol. 52, pp. 139- 145 ,(1997) , 10.1007/S002280050263
John Mendelson, Robert A. Upton, E. Thomas Everhart, Peyton Jacob III, Reese T. Jones, Bioavailability of Sublingual Buprenorphine The Journal of Clinical Pharmacology. ,vol. 37, pp. 31- 37 ,(1997) , 10.1177/009127009703700106
Shu-Feng Zhou, Charlie Changli Xue, Xue-Qing Yu, Chunguang Li, Guangji Wang, Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring Therapeutic Drug Monitoring. ,vol. 29, pp. 687- 710 ,(2007) , 10.1097/FTD.0B013E31815C16F5
Cynthia L. Osowski, Suzanne P. Dix, Lillian S. Lin, Richard E. Mullins, Robert B. Geller, John R. Wingard, Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients Transplantation. ,vol. 61, pp. 1268- 1272 ,(1996) , 10.1097/00007890-199604270-00026
Barbara Grün, Stefanie Krautter, Klaus-Dieter Riedel, Gerd Mikus, Inhibition of the active principle of the weak opioid tilidine by the triazole antifungal voriconazole British Journal of Clinical Pharmacology. ,vol. 68, pp. 712- 720 ,(2009) , 10.1111/J.1365-2125.2009.03498.X
Michiteru Ohtani, Basic pharmacology of buprenorphine European Journal of Pain Supplements. ,vol. 1, pp. 69- 73 ,(2007) , 10.1016/S1754-3207(08)60017-6